Cellares vs CTIBIOTECH USA
Cellares vs CTIBIOTECH USA, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellares is on 54/100 and CTIBIOTECH USA on 46/100.
Where each one leads
Cellares
- our overall score: 54/100 against 46/100
- domain rating: 43/100 against 30/100
- funding raised: $327M against $4.3M
CTIBIOTECH USA
- agent readiness: 50/100 against 42/100
At a glance
| Measure | Cellares | CTIBIOTECH USA |
|---|---|---|
| What it is | The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies. | North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences | Biotechnology, Healthcare, 3D Printing, Regenerative Medicine |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2019 | 2024 |
| Headquarters | South San Francisco, USA | Philadelphia, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellares | CTIBIOTECH USA |
|---|---|---|
| Employees | Not published | 22 |
| Total funding | $327M | $4.3M |
| Latest round | Funding Round | Undisclosed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 7,543 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellares | CTIBIOTECH USA |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 46/100 |
| Traction | 40/100 | 47/100 |
| Search visibility | 15/100 | 31/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 43/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellares | CTIBIOTECH USA |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Astro |
| Analytics | Google Analytics 4 | Not detected |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Cellares | CTIBIOTECH USA |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 0 negative across 4 threads | Not published |
“Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel.”r/CABAinvest
Cellares vs CTIBIOTECH USA: common questions
Which is better, Cellares or CTIBIOTECH USA?
On our 0-100 score Cellares rates higher (54/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Cellares and CTIBIOTECH USA compare on the numbers?
Cellares leads on our overall score (54/100 against 46/100), domain rating (43/100 against 30/100), funding raised ($327M against $4.3M). CTIBIOTECH USA leads on agent readiness (50/100 against 42/100).
What do real users say about Cellares and CTIBIOTECH USA?
Cellares: 2 positive and 0 negative mentions across 4 Reddit threads we track, mostly in r/CABAinvest.
Read the full Cellares review and pricing or the CTIBIOTECH USA review and pricing. You can also browse other Cellares alternatives we track.